chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Passed out after receiving COVID vaccine, brief loss of consciousness then regained consciousness and was able to speak quickly after, PAGED code white (store management) to the pharmacy, and called paramedics, no reason to feel that epipherine or benadryl was necessary.
This spontaneous report was received from a nurse practitioner via a company representative referring to a 67 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date in 2015, the patient received a dose of ZOSTAVAX vial, 1 dose (dose, route of administration, anatomical location, lot number and expiration date were not provided) for prevention of shingles. On an unknown date, reported as after receiving ZOSTAVAX, the patient developed shingles. It was unknown whether a treatment was given for the adverse event. At the time of the report, the patient was recovered from shingles. The causal relationship between ZOSTAVAX and shingles was not reported. This is one of two reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1702USA001824.
Trigeminal Neuralgia - slight sensations after the first vaccine.  Very strong pain after the second
16 YEAR OLD FEMALE RECEIVED MODERNA BRAND VACCINE TODAY AS HER FIRST DOSE. PER GUIDANCE HER 2ND VACCINE IN 4 WEEKS SHOULD ALSO BE MODERNA
I observed an inflamed itchy area just below the injection site on Day 9. The inflammation broadened and spread downward over the next two days, reaching about 7 inches in length and 3 inches in width by Day 11. I consulted a dermatologist then. She recommended a double strength dose of Zyrtec and application of Triamcinolone ointment to the inflamed area.  Over the next two days, this therapy halted the spread and reduced the inflammation, so that it was essentially gone by Day 13.
Diarrhea; temp 102 F; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and PYREXIA (temp 102 F) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's medical history information was not provided.  Concomitant products included LORATADINE (CLARITIN [LORATADINE]) from 10-Mar-2021 to an unknown date for Prevention.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and PYREXIA (temp 102 F). At the time of the report, DIARRHOEA (Diarrhea) and PYREXIA (temp 102 F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Body temperature: 102°f (abnormal) abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.
Approximately 36 hrs after vaccinations I received unusual pimples on my face, arms and torso.  They began as bright red and eventually formed white heads.  After a week, the pimples still were forming breaking and then new ones reformed after.  No more than about 20 blisters at any one time, mostly on the torso.  At the same time my joints started to feel extremely sore.  My ankles, knees, shoulders, elbows, wrist, each small joint in my hands& fingers and neck all feel like they were all sprained/strained.  It has been 12 day since vaccination.
This report was received from GLAXOSMITHKLINE and was assigned manufacturer report number A0944333A, concerning an 18 year old female with fainting and no adverse events following previous vaccinations, who on 07-SEP-2011 was vaccinated with the first dose of MMR II (lot # 668072/1509Z, batch # G001279). Concomitant therapy included the first 0.5 ml dose of TWINRIX (lot # not reported) vaccinated into left arm at 11:15 on 07-SEP-2011 while in a seated position, triamcinolone and FLONASE. On 07-SEP-2011, immediately after vaccination with TWINRIX, the subject experienced syncope and fell. The patient had a seizure immediately following MMR II injection. Fainting was also reported. The healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). The patient was taken to the emergency room where she was discharged the same day. A systemic shot reaction was reported. The patient was told by cardiology that she had experienced a vasovagal response. Syncope, seizure, fainting and falling were all reported to have resolved. Attribution of the events to vaccination with TWINRIX was not reported. This was originally reported by a health professional. A lot check has been initiated. Additional information has been requested.
patient received expired vaccine; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 000134A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 28-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received expired vaccine) outcome was unknown.            No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.
pt recv vax 14AUG95 & 1MAY96 pt devel rash w/approx 30-40 lesions;exp was dx as active chickenpox;MD reported 3 patients w/the same exp;
HA, nausea and fatigue-started 3 hrs after and still present. Severe HA with high pitched ringing in bilat ears and N/V/D-onset 08/19/21. severe HA with high pitched ringing in bilat ears and nausea still present. Intermittent vomiting and diarrhea still present. Redness, swelling, heat and pain to inj site-30 mins onset. Redness subsided 08/20/21. Presently pain and slight swelling and heat. Visual disturbances, altered perception depth and vertigo-onset 08/20/21 and still present. Mild rash to rt axillary region and upper abd-onset 08/24/21. Subsided 08/26/21. Malaise and fatigue-onset 08/19/21 and still present. Concentration difficulty-onset 08/18/21 and currently present. Burning sensation to RUE concentrated at inj site, ranging from mild to moderate. Exacerbation of psoriasis. Onset 08/20/21 and continually worsening.
On Monday evening, May 9, 2022, I had a scratchy throat and my lymph nodes were slightly swollen. It seemed like I was coming down with a breakthrough case of COVID despite having gotten my 2nd booster two weeks earlier. Over the next few days I had a runny nose, big sneezes, muscle aches, and some tiredness so it sure looked like I had COVID. On Monday, my wife (65 years old and vexed and boosted once) took a rapid COVID test and was positive. She had traveled by airplanes on Wednesday and Friday the previous week. and probably picked it up on that trip.  On Tuesday, May 10, I took a rapid COVID test, but I was negative. I talked with my doctor about this and she said if I wanted to take Paxlovid, I needed a positive PCR test. So on Wednesday, May 11, I went to office and had a PCR test, but it also came back negative. So I did not take Paxlovid. Both my wife and I continued to have mild symptoms with her symptoms less than mine. Yesterday, May 16, 2022 my wife was tested at her workplace and the PCR showed her still positive.  We are both mostly fine -- we both have some excess mucus and periodic coughing, but we are mostly ok now.   Our cases look like just regular breakthrough COVID cases and not very interesting. But it occurred to me today that since I had just been boosted, it could be that this case might be of interest to you. Perhaps my getting boosted recently meant that even though I most likely have COVID, I am still  testing negative while my wife is testing positive.
Migraine; foggy most of day or all day; Headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 18Apr2021 at 10:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 27Mar2021 at 09:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 08:00, the patient experienced headache, migraine and was foggy most of the day or all day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, migraine and foggy most of the day or all day were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Difficulty breathing (especially taking deep breaths), inability to exercise, chest pain. Symptoms started about a week after the first vaccine shot on 4/2/21 and gradually got worse until the second shot on 5/1/21 which resulted in a fever, shortness of breath and a drop in blood oxygen to 92%. Went to ER on 5/4/21 and got a breathing treatment, CT, EKG, Chest X-ray, and COVID test. All returned normal results and negative on COVID. Referred to Pulmonary specialist.   Given Flonase and Rest. Outcome of tests run indicate Mild Myocarditis was contracted as a result of the vaccine.
Sweaty palms and blood pressure went up within 10 minutes of vaccine but then it started to go down so I left.  I normally have low blood pressure.  A few days later I got LOUD tinnitus and some ear popping.
pt recvd vax; to ofc w/ inject site rxn of erythema, tenderness, swelling; apap & ice packs used;
4-3-12 Pink swelling at injection site left upper arm (SC). Painful. 4-4-12 Left side of face, neck, arm & hand tingling & numb.
Flu-like symptoms; Fever; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) had resolved.            No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-436309, MOD-2021-436373, MOD-2021-436047 (Patient Link).
Patient received the Shingrix as an extra vaccine.  Shingrix is for ages 50 years and older.  She was to receive her Meningococcal vaccine.  No adverse events were reported.
April 6, 2021 was the first day of my last period. On April 22, 2021, I received the first dose of the Phizer vaccine. I had no symptoms after this first shot. On May 6, 2021, I discovered a brown discharge in my underwear and felt a little nauseous. On May 8, 2021, I discovered a brown discharge in my underwear and felt a little nauseous. On May 9, 2021 I woke up feeling very nauseous and had the chills. On May 11, 2021, I discovered bright red when I wiped after using the bathroom. On May 13, 2021, I received the second dose of the Phizer vaccine. I felt very tired, weak, body aches, and a strong headache. It lasted for 24-hours and lifted. A week later I started to experience a very strong nausea that would last throughout the night and even wake me up from sleep. I also experienced perioral dermatitus around my mouth. A dermatologist determined my body was under stress and reacting in this manner. On May 28, 2021 I took an at home pregnancy test and received a positive result. On June 7, 2021, I took a second pregnancy test to confirm my pregnancy. On June 23, 2021, I went in for an ultrasound at 11 weeks pregnant and Dr. discovered my uterus was filled with cysts. She could not locate the fetus among the cysts. The following day, June 24, 2021, I had bloodwork drawn. My HcG levels were 124,913. My doctor reasoned that I was having a molar pregnancy. On June 25, 2021, I went in for a D&C surgery to have my uterus vacuumed out. The specimens were sent to two independent labs. The first lab reported this was not a molar pregnancy. The second lab concluded from the specimen tests that this was not a molar pregnancy. A genetics lab concluded the baby was a girl. My charts have been referred to ongoing studies to figure out what caused this miscarriage to happen and why my bloodwork and ultrasound look like a molar pregnancy but lab reports find no evidence of a molar pregnancy.
This spontaneous report was received from a physician via a company representative concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported.     On an unspecified date in 2017, the patient was vaccinated with an expired dose of VAQTA 50/1 U/ml, intramuscularly, expiration date:26-MAY-2017, as prophylaxis (Dose and lot # were not reported). No adverse effects were reported. Additional information is not expected as contact details were not provided.
she has sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 71 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "she had sore arm".  Additional information: Caller stated that the patient took her first dose of the Pfizer covid vaccine today, about 5 hours ago and had sore arm but no other symptoms. The patient also stated she had allergy shot due next week.  No follow-up attempts are possible. No further information is expected.
Post vax, I experienced discomfort at the injection site, fever of 101F-103.6F, headache, dizziness, nausea, fatigue/weakness, diarrhea x 1 day, abdominal cramps and rash on legs, chest and neck. Saw doctor on 8/14/00 and treated with prednisone for 2 days
muscle cramps; lightheaded dizziness; eyes felt dry; muscles in face felt tight; bladder started to act up and urination every few minutes; pressure around eyes; tingling in tongue; not feeling herself; muscle tightness; tiredness; soreness; began to vomit; headaches; chills; drop in blood sugar in a friend; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (drop in blood sugar in a friend), PARAESTHESIA ORAL (tingling in tongue), MALAISE (not feeling herself), DRY EYE (eyes felt dry) and FACIAL DISCOMFORT (muscles in face felt tight) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Influenza vaccine in February 2021. Past adverse reactions to the above products included Adverse event with Influenza vaccine.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jan-1900, the patient experienced BLOOD GLUCOSE DECREASED (drop in blood sugar in a friend). On 09-Apr-2021, the patient experienced PARAESTHESIA ORAL (tingling in tongue), MALAISE (not feeling herself), MYALGIA (muscle tightness), FATIGUE (tiredness), INJECTION SITE PAIN (soreness), VOMITING (began to vomit), HEADACHE (headaches) and CHILLS (chills). On 10-Apr-2021, the patient experienced DRY EYE (eyes felt dry), FACIAL DISCOMFORT (muscles in face felt tight), POLLAKIURIA (bladder started to act up and urination every few minutes) and PERIORBITAL DISCOMFORT (pressure around eyes). On 15-Apr-2021, the patient experienced MUSCLE SPASMS (muscle cramps) and DIZZINESS (lightheaded dizziness). At the time of the report, BLOOD GLUCOSE DECREASED (drop in blood sugar in a friend), PARAESTHESIA ORAL (tingling in tongue), MALAISE (not feeling herself), DRY EYE (eyes felt dry), FACIAL DISCOMFORT (muscles in face felt tight), POLLAKIURIA (bladder started to act up and urination every few minutes), PERIORBITAL DISCOMFORT (pressure around eyes), MUSCLE SPASMS (muscle cramps), DIZZINESS (lightheaded dizziness), MYALGIA (muscle tightness), FATIGUE (tiredness), INJECTION SITE PAIN (soreness), VOMITING (began to vomit), HEADACHE (headaches) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       .   This case was linked to MOD21-085383, MOD21-085590, MOD21-085592, US-MODERNATX, INC.-MOD-2021-101678 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD21-085383: MOD21-085590: MOD21-085592: US-MODERNATX, INC.-MOD-2021-101678:
Pharmacy accidentally administered expired vaccine for both doses (6/16/22 and 7/18/22), expiration date was 2/8/22. Error was discovered when checking stock for an upcoming appointment. Manufacturer has been contacted and they recommend not considering these doses valid and repeating them. Patient is aware and wants to repeat doses at the pharmacy. Patient does not report any adverse events.
Cycles of abdominal pain with calm periods in between, all day and woke her from sleep at night. Developed bloody stools on 3/9/16.
Report A0371638A describes joint pain and swelling in a 65 year old female who received Lyme disease vaccine recombinant OspA. This report was received from the vaccinee's spouse and has not been verified by a physician or other health care professional. Medical history and concomitant conditions were not provided. Concurrent medications included Zocor, Evista, and Miacalcin. Reportedly, the vaccinee received her third injection of LYMErix in October 1991 (believed to be 1999). On 6/10/22, the vaccinee began to experience joint pain with swelling. The vaccinee was seen by a physician who reportedly told her that she may have Lyme disease. The adverse events of 'joint pain' and 'joint swelling' do not meet serious criteria, but are being submitted as an expedited report by special FDA request per the 6/28/00 letter.  Follow up on 02/26/04: "The health care professional reported that the joint pain and swelling began on 06/04/02.  On physical examination, swelling of the right wrist and left "ankle/foot" was observed. Erythrocyte sedimentation rate and rheumatoid factor were elevated. Antinuclear antibody was negative. Lyme antibody screen was positive, but IgG and IgM Western blots were negative.  Please see lab data section. The health care professional made a diagnosis of "rheumatoid arthritis versus reactive arthritis". He considered the events to be unrelated to LYMErix administration. As of 01/29/03, the outcomes of the events were unknown."
The employee reports that she developed symptoms consistent with Bell's Palsy about 48 hours after receiving the vaccine. She states that the left side of her face is swollen and itchy. The employee has been takin Benadryl every 4 hours to keep the swelling down.
Information has been received from a nurse via company representative concerning a 12 year old male patient who on 01/07/1992 was vaccinated with a first dose of measles virus vaccine live (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) and there were no problems.  On 09/09/2003 the patient received his second dose of measles virus vaccine live (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (645267/0101N).  On 09/15/2003 the patient developed facial swelling, genital swelling and fever.  As of 09/27/2003 the patient's experiences continued and the patient was started on cephalexin (Keflex).  Admission to the hospital was planned due to continued facial swelling.  Upon internal review, continued facial swelling was considered to be an important medical event (OMIC).  Additional information has been requested. Follow up 3/15/05: Patient has not recovered.
My right hand was very sore and was not able to close it completely for 24 hours on 3-18-2021 and a week later on 3-25-2021 my right leg was sore and was not able to stand on it with full weight. I used a walking cane for (3) days 3-18-2021 to 3-20-2021.
More painful than any other injection patient has received thus far. Patient still has issues with weight bearing with left arm.
Tinnitus. Loudness increased with boosters. I received the initial two doses and a booster six months later. I received another booster one year after the first booster. I then quit getting vaccinations because the side effect (tinnitus) increased. It remains LOUD.
Patient stated today, 5/11/21, 24 hours after receiving the first dose of Moderna she passed out and had a seizure.  Roomate called 911, she was taken to the hospital, treated and followed up with a neurologist.
I am allergic to Food dyes, preservatives; Polysorbate and PEG.  I came down with Bell's Palsy on the right hand side of my face.  Went to Emergency Room for Steroids, Anti-viral medication, eye drops, eye tape.
Pt called 8/28 of arm soreness, pain and edema asked pt to apply ice packs and take ES TYLENOL, which she did and if no improvement come to the office on 8/29. 8/29/17 C/O pain, edema and stiffness after PNEUMOVAX yesterday did apply ice and take ES TYLENOL. TYLENOL helped pain and ice on 15/off 15 min. Swelling has improved. (L) arm edematous, erythematous, warm and firm to touch surrounding injection site, decreased about 7 inches below inj. site.
FATIGUE/TIREDNESS; This spontaneous report received from a patient concerned an adult female. The patient's height, and weight were not reported. The patient's concurrent conditions included: moderate to severe adult crohn's disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose, start therapy date were not reported for covid-19 vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.   Non-company suspect drugs included: adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for moderate to severe adult crohn's disease.  No concomitant medications were reported.  On an unspecified date, the patient experienced fatigue/tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fatigue/tiredness. This report was non-serious.